LEADER 02432nam 2200553 a 450 001 9910829196503321 005 20200520144314.0 010 $a1-62417-108-7 035 $a(CKB)2550000001043645 035 $a(EBL)3021735 035 $a(SSID)ssj0001179325 035 $a(PQKBManifestationID)11671712 035 $a(PQKBTitleCode)TC0001179325 035 $a(PQKBWorkID)11181348 035 $a(PQKB)10257228 035 $a(MiAaPQ)EBC3021735 035 $a(Au-PeEL)EBL3021735 035 $a(CaPaEBR)ebr10683475 035 $a(OCoLC)923666792 035 $a(EXLCZ)992550000001043645 100 $a20120921d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aADHD$b[electronic resource] $ecognitive symptoms, genetics and treatment outcomes /$fRussell Thompson and Naomi J. Miller, editors 210 $aNew York $cNova Biomedical$d2013 215 $a1 online resource (152 p.) 225 1 $aNeurodevelopmental diseases--laboratory and clinical research 225 1 $aNeurology--laboratory and clinical research developments 300 $aDescription based upon print version of record. 311 $a1-62417-107-9 320 $aIncludes bibliographical references and index. 327 $aFunctionality of the ADHD individual : the disadvantages and benefits of stimulant treatment -- Family dynamics, conversations and attachment patterns : the construction of ADHD -- Do professions differ in their beliefs about the causes and treatment of attention-deficit hyperactivity disorder? -- Motor coordination dysfunction in ADHD : new insights from the classroom to genetics -- Importance of nutrition optimization in multimodal treatment in children with attention-deficit hyperactivity disorder -- The relation between sluggish cognitive tempo and ADHD : a critical review. 410 0$aNeurodevelopmental diseases--laboratory and clinical research series. 410 0$aNeurology--laboratory and clinical research development series. 606 $aAttention-deficit hyperactivity disorder 615 0$aAttention-deficit hyperactivity disorder. 676 $a616.8589 701 $aThompson$b Russell$01614552 701 $aMiller$b Naomi J$0870094 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910829196503321 996 $aADHD$93944392 997 $aUNINA